Targeting PP2A activates AMPK signaling to inhibit colorectal cancer cells

LB-100 is a novel PP2A inhibitor. Its activity in human colorectal cancer (CRC) cells was tested. The in vitro studies demonstrated that LB-100 inhibited survival and proliferation of both established CRC cells (HCT-116 and HT-29 lines) and primary human colon cancer cells. Further, LB-100 activated...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Cuiping, Zhang, Xuning, Xie, Da, Tang, Peipei, Li, Chunmei, Zuo, Yi, Jiang, Baofei, Xue, Caiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707063/
https://www.ncbi.nlm.nih.gov/pubmed/29221169
http://dx.doi.org/10.18632/oncotarget.21336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707063/
https://www.ncbi.nlm.nih.gov/pubmed/29221169
http://dx.doi.org/10.18632/oncotarget.21336

Ejemplares similares